Bibliometric and visual analysis of ferroptosis in cardiovascular diseases Authors: Xianghu Zhao, Xiaohan Cao, Lan Lei, Wenyuan Xu, Yujie Guo, Yikang He Published: 2025 ABSTRACT AbstractBackgroundFerroptosis, an emerging form of cell death, holds substantial promise for elucidating the etiology and improving treatment methods for cardiovascular diseases (CVDs). This work aims to comprehensively analyze cutting-edge research and future trends in CVDs, guiding research progress and the development of new therapies.Methods We retrieved articles and reviews related to ferroptosis in CVDs from the Web of Science Core Collection database, spanning the period from January 1, 2016, to April 22, 2025. Visualization and statistical analysis were performed using CiteSpace (6.2.R3) and VOSviewer (1.6.19) software.ResultsThe bibliometric analysis of ferroptosis in CVDs reveals a significant increase in research output since 2016, with a peak in publications in 2024. China leads in publication volume, with Southern Medical University being a key contributor. The International Journal of Molecular Sciences is the most prolific journal, and authors like Zhang Jing have the highest publication counts. Research focus has shifted over time, with recent emphasis on “cardiovascular diseases,” “myocardial infarction,” “lipid metabolism,” “autophagy,” and “mitochondrial dysfunction.”Conclusions Our bibliometric analysis reveals the rapid growth and evolving focus of ferroptosis research in CVDs, with China and the USA leading in output. Future work should prioritize developing biomarkers, multi-omics analyses, and the elucidation of specific molecular mechanisms to enhance clinical translation. Global collaboration remains key to accelerating innovation in this field.Keywords: Bibliometric analysis, Ferroptosis, Cardiovascular diseases, Citespace, Vosviewer, Visual analysis Introduction Cardiovascular diseases (CVDs) remain the primary cause of non-communicable disease mortality worldwide, with ischemic heart disease representing the most significant epidemiological burden [1]. Recent data indicate that CVDs account for over 17.9 million deaths annually, emphasizing the urgent need for novel therapeutic insights [2]. The paradigm-shifting discovery of ferroptosis in 2012 established an iron-dependent mode of regulated cell death, distinct from classical apoptosis or necrosis through its unique dependence on lipid peroxidation and glutathione depletion [3]. While early research predominantly focused on its roles in oncology and neurodegenerative disorders [4], recent years have witnessed accelerated migration of ferroptosis investigations into cardiovascular pathophysiology [5]. Compelling evidence now implicates ferroptotic cell death in myocardial infarction progression, doxorubicin-induced cardiotoxicity, and atherosclerotic plaque instability [6]. Despite exponential growth in publications, the research landscape of ferroptosis and cardiovascular diseases remains fragmented and lacks a well-defined intellectual structure. Only a few studies have systematically analyzed the collaborative networks across institutions and countries, visualized the evolution of knowledge with patterns of interdisciplinary convergence, or identified emerging hotspots, such as the associations between various types of cell death and CVDs [7]. Traditional narrative reviews cannot objectively capture these multidimensional dynamics, whereas bibliometric analysis addresses this critical gap by providing quantitative mapping of research trends, collaborative patterns, and knowledge diffusion pathways [8–10]. Currently, several bibliometric analyses of ferroptosis in CVDs have been published [11]. However, previous studies have been limited in their analytical approaches, which has precluded a more in-depth analysis of mechanisms and future research trends. To bridge this gap, we conducted the comprehensive bibliometric analysis of ferroptosis in CVDs using CiteSpace (6.2.R3), VOSviewer (1.6.19), and Microsoft Excel 2021. This study aims to map the scientific collaboration network since 2016, identify burst keywords signaling frontier topics, profile core journals, and high-impact authors, and ultimately translate findings into strategic priorities for future research clinical translation. Methods Data collection The selected time frame (January 2016 to April 2025) encompasses the significant progress and growing attention in the field of ferroptosis research in CVDs, starting from when the association between ferroptosis and CVDs began to attract attention [12] and ending with the most recent data available at the time of our study. From the Web of Science Core Collection (WoSCC) and were downloaded on April 22, 2025. The search criteria employed were: [TS=(“cardiovascular disease” OR “heart disease” OR “coronary artery disease”) AND TS=(ferroptosis)], and the time span for publications was from “2016-01-01” to “2025-04-22,” ultimately retrieving 525 records. We filtered out non-valid publications, specifically: early access articles (n = 9), meeting abstracts (n = 3), editorial materials (n = 3), retracted publications (n = 1), book chapters (n = 1), and non-English literature (n = 1). A total of 507 publications were ultimately included for analysis after rigorous screening, and the relevant records were performed and preserved in plain text format (Fig. 1). Flowchart of the study Data visualization The relevant literature records obtained from the WoSCC were exported in plain text (.txt) format for subsequent bibliometric analysis. All raw data underwent systematic preprocessing in Microsoft Excel 2021 (Microsoft Corporation, Redmond, WA, USA), including deduplication, format standardization, and metadata verification. This structured dataset enabled quantitative analysis of publication volume, citation frequency, and disciplinary distribution patterns. The bibliometric analysis was performed utilizing VOSviewer 1.6.19 (Centre for Science and Technology Studies at Leiden University) and CiteSpace 6.2.R3 (developed by Chaomei Chen, Drexel University, USA) to systematically investigate collaboration patterns, knowledge structures, and research frontier. Visualization parameters Network layouts were generated using CiteSpace’s force-directed algorithm with modularity optimization (Q > 0.7 indicating significant clustering). Cluster labels were extracted through log-likelihood ratio testing to ensure semantic relevance. All visualizations underwent 3 iterations of parameter tuning to balance interpretability and analytical rigor [13]. Notably, in VOSviewer, we applied “full counting” for normalized data processing. For cluster analysis of authors, institutions, and countries or regions, a minimum threshold of three publications and citations was set. Additionally, the Walktrap method was used in thematic map analysis for more precise topic delineation, while other analyses adhered to default software thresholds. By using these visualization methods, this study provided researchers in related fields with an intuitive and clear understanding of the research landscape. Results General analysis Annual publication counts and citation frequencies Research on ferroptosis in CVDs began to gain attention around 2016, with one of the first key studies appearing that year. From to 2025, both the number of publications and citation counts demonstrated a consistent upward trend. Given the limited number of relevant publications in 2025 (as of the data retrieval cutoff date of April 22), this analysis compiled a comprehensive annual dataset spanning from to 2024. This dataset comprises 410 publications, which were selected from an initial pool of 507 publications. A cubic regression model was utilized to analyze the Temporal trend in publication output, with an R² value of 0.8101 (Fig. 2). The bar chart illustrates the inception of this field, marked by its first publications in (n = 2), and shows a peak annual output in 2024 (n = 248). Concurrently, the line graph depicts the Temporal pattern of average annual citations, which reached a maximum in 2024 (9,772 citations) Yearly publication and citation dynamics associated with ferroptosis in CVDs. Blue bars denote publications, while yellow bars indicate citations Investigation of research fields The disciplinary distribution analysis identified 3 dominant fields: Biochemistry & Molecular Biology (129 papers), Pharmacology & Pharmacy (109 papers), and Cell Biology (102 papers) (Fig. 3). The top10 research areas about ferroptosis in CVDs Countries/regions and institutional analysis Analysis of countries/regions A total of 1,188 institutions across 63 countries and regions produced papers. Table 1 presents the top 10 productive countries/regions. The leading 5—China (34.57%), the USA (4.31%), Germany (0.93%), Iran (0.93%), and Italy (0.84%)—together contributed 41.58% of all publications. Table 1The 10 leading institutions and countries/regions in terms of publication outputNO.InstitutionsCountCountriesCount1Southern Medical University21China3982Chinese Academy of Medical Sciences-Peking Union Medical College18USA513Harbin Medical University17Germany114Zhejiang University16Iran115University of South China15Italy106Nanjing Medical University15South Korea77Wuhan University14Canada68Central South University13France69Huazhong University of Science & Technology12Poland610Capital Medical University12Japan5 The 10 leading institutions and countries/regions in terms of publication output Analysis of publication output and collaboration This analysis not only reflects the publication output of countries through node size but also highlights centrality (exceeding 0.1) via purple nodes. (Fig. 4A). The analysis included countries with more than 2 publications. Furthermore, the formation of a tight collaborative bond between China and the USA underscores the intrinsically global character of research activities in this area (Fig. 4B). The visualization map of countries/regions associated with ferroptosis in CVDs. (A) The size of the nodes indicates the number of publications from these countries/regions, and the links between nodes signify the collaborative relationships between these countries/regions. (B) Global collaboration network map Analysis of institutions Table 1 presents the 10 most prolific institutions among 1,188 research organizations, all based in China. The leading 5 are Southern Medical University (21 papers), Chinese Academy of Medical Sciences-Peking Union Medical College (18 papers), Harbin Medical University (17 papers), Zhejiang University (16 papers), and University of South China (15 papers). The collaborative connections among various institutions are effectively illustrated (Fig. 5). In this network visualization, every node represents a distinct institution, with the node size indicative of the institution’s frequency of collaboration or the volume of publications. The connections between nodes indicate collaborative relationships among institutions. The color legend denotes different years, providing a temporal context to the collaborations observed. Notably, institutions including Zhejiang University, the University of South China, and the Chinese Academy of Medical Sciences-Peking Union Medical College are prominently positioned within the network. The visualization map of institutions associated with ferroptosis in CVDs. The size of nodes corresponds to the number of papers published by the institutions. The connections between nodes signify the collaborative ties among these institutions Journals and Co-cited journals Journal analysis Within the domain of ferroptosis in CVDs, a substantial volume of research has been published across various academic journals. Since 2016, a notable number of articles have been published in key journals, significantly contributing to the advancement of knowledge. Among these, certain journals have consistently held a prominent position in the publication landscape. The International Journal of Molecular Sciences, Frontiers in Cell and Developmental Biology, Circulation Research, and Frontiers in Cardiovascular Medicine have been particularly influential, with a high number of papers. Co-cited journals analysis Co-citation analysis is a valuable tool for understanding the intellectual structure of a scientific area by identifying the relationships between journals based on their co-citation patterns. In our work, CiteSpace was employed to analyze journal co-citation, revealing a network of 631 journals that have been co-cited in the context of ferroptosis in CVDs. This analysis highlighted several journals that have been frequently co-cited. Notably, journals including Nature, Proceedings of the National Academy of Sciences of the United States of America, and PloS One have been co-cited numerous times. (Fig. 6; Table 2) The visualization map of Co-cited journals associated with ferroptosis in CVDs. The size of nodes corresponds to the number of citations of the journals. The connections between nodes signify the co-citation associations between the journals Table 2The top 10 co-cited journal in terms of publication volumeNO.CountCo-cited Journal1385Cell2370Free Radical Bio Med3328Cell Death Dis4318Nature5317P Natl Acad Sci Usa6306Int J Mol Sci7303Redox Biol8299Circ Res9289Circulation10277Cell Death Differ11274Oxid Med Cell Longev12270Front Pharmacol13259Biochem Bioph Res Co14250J Biol Chem15247Sci Rep The top 10 co-cited journal in terms of publication volume Overlay analysis of high-frequency citing and cited journals In this work, CiteSpace software was utilized to generate a dual-layer overlay map of journals, visually depicting the complex interrelationships between citing journals (on the left) and cited journals (on the right) within the research domain of ferroptosis and CVDs (Fig. 7). The analysis identified that the citing journal cluster characterized by “Molecular, Biology, Immunology” and the core cited journal cluster centered by “Molecular, Biology, Genetics” serve as key nodes in the journal-level knowledge flow pathway (z score = 6.653889; f = 16008). Subsequently, a robust link exists between the “Medicine, Medical, Clinical” citing journals and the “Molecular, Biology, Genetics” cited journals (z score = 2.4546561; f = 6338). Dual-map overlay of journals showing the citation links between citing journals on the left and cited journals on the right, with line thickness indicating the strength of these citation connections Co-citation analysis and burst detection of references Co-citation analysis Co-citation occurs when 2 or more publications are referenced together by 1 or more articles [14]. In this analysis, we focused on publications that have been co-cited a minimum of 20 times. Several core references, particularly those focusing on the GPX4/GSH/SLC7A11 antioxidant system, have emerged as highly influential and are frequently co-cited [15]. To clarify, Glutathione Peroxidase 4 (GPX4) is an enzyme that plays a crucial role in protecting cells from oxidative damage; Glutathione (GSH) is a key antioxidant; and SLC7A11 is a solute carrier protein involved in the regulation of cellular cystine and glutamate levels, which are critical for ferroptosis. Among the 10 primary highly co-cited publications, 9 were experimental research, and 1 was a review article. The most co-cited reference in ferroptosis in CVDs was “FTO-dependent N6-methyladenosine regulates cardiac function during remodeling and repair,” authored by Mathiyalagan and published in Circulation [16]. To clarify, Fat mass and obesity-associated protein (FTO) is involved in the demethylation of N6-methyladenosine (m6A), a post-transcriptional modification that regulates gene expression and is particularly relevant in the context of cardiac function during remodeling and repair. This reference was followed by the article entitled “The N6-methyladenosine mRNA methylase METTL3 controls cardiac homeostasis and hypertrophy” [17]. To further explain, Methyltransferase Like 3 (METTL3) is a key enzyme responsible for the methylation of N6-methyladenosine (m6A) in mRNA, which plays a crucial role in regulating cardiac homeostasis and hypertrophy. These studies highlight the importance of m6A modifications in cardiovascular diseases. (Table 3) Table 3Top 15 articles in terms of co-citation frequencyNO.CountYearAuthorCite References11642019Xuexian FangFerroptosis as a target for protection against cardiomyopathy21062020Tao BaiInhibition of ferroptosis alleviates atherosclerosis through attenuating lipid peroxidation and endothelial dysfunction in mouse aortic endothelial cell3942021Xuejun JiangFerroptosis: mechanisms, biology and role in disease4912020Jie LiFerroptosis: past, present and future5912020Xuexian FangLoss of cardiac ferritin H facilitates cardiomyopathy via Slc7a11-mediated ferroptosis6892023Xuexian FangThe molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease7802019Kirill BersukerThe CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis8762019Sebastian DollFSP1 is a glutathione-independent ferroptosis suppressor9752021Xiaoguang WuFerroptosis as a novel therapeutic target for cardiovascular disease10652020Ning LiFerritinophagy-mediated ferroptosis is involved in sepsis-induced cardiac injury11652020Tomonori TadokoroMitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity12652021Daolin TangFerroptosis: molecular mechanisms and health implications13632020Wenyuan LiFerroptosis is involved in diabetes myocardial ischemia/reperfusion injury through endoplasmic reticulum stress14612019Matthew DodsonNRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis15602019Tae-Jun ParkQuantitative proteomic analyses reveal that GPX4 downregulation during myocardial infarction contributes to ferroptosis in cardiomyocytes Top 15 articles in terms of co-citation frequency Co-citation burst detection Burst detection highlights events that happen with unusual frequency or suddenness within a specific timeframe. Co-cited references burst detection can identify substantial fluctuations in citations within a defined timeframe [18]. It is applied to pinpoint the increase or decline of a particular co-cited study. As presented in the provided data, the top 15 references with the highest citation bursts were recognized. The first reference to exhibit citation bursts dates back to 2015, titled “Ferroptosis as a p53-mediated activity during tumour suppression” by Jiang L. and published in Nature [19]. From 2015 onward, the number of cited studies has risen annually. Of the 15 studies, several exhibited bursts in prior years and persisted until 2022. Papers published after 2019 were all featured in high-impact journals. For instance, the reference by Xie Y., published in 2016 in Cell Death Differ, shows a strong citation burst from 2018 to 2021 with a strength of 18.89 [12]. Similarly, the study by Stockwell BR., published in 2017 in Cell, exhibits a significant burst from 2019 to 2022 with a strength of 30.35 [4]. The data also shows that references published in 2015 and 2016, such as those by Gao MH [20]. and Cao JY [21]., experienced citation bursts that lasted until 2020 and 2021, respectively. (Fig. 8) Top 15 references with the most significant citation bursts. The blue bar shows that the reference has been published; the red bar represents a citation explosion Authors and co-cited authors Analysis of authors The dataset included 5,116 authors in 847 studies. Table 4 illustrates the top 10 authors based on their publication counts. Zhang, Jing leads with the highest number of papers (n = 8), followed by Zhang, Yan (n = 5), Wang, Ying (n = 4), and Li, Wei (n = 4). Table 4The 10 leading authors and co-cited authorsNO.CountAuthorCountCo-cited author18Zhang, Jing433Dixon Sj25Zhang, Yan351Fang Xx34Wang, Ying275Stockwell Br44Li, Wei274Yang Ws53Liu, Ying212Doll S63Zhu, Lin202Gao Mh73Chattipakorn, Siriporn C178Li J83Yang, Fan178Angeli Jpf93Wang, Shuai178Chen X103Meng, Ning150Wang Y The 10 leading authors and co-cited authors Co-citation analysis of authors Co-cited authors are recognized when they are cited together in 1 or more academic papers. In the analysis presented, a total of 10 authors were identified as the most frequently co-cited. Table 4 provides a ranking of these authors based on their co-citation counts. Dixon SJ leads the list with 433 co-citations, followed by Fang XX with 351. Stockwell BR and Yang WS are next, each with 275 and 274 co-citations respectively. The remaining authors, Doll S, Gao MH, Li J, Angeli JPF, Chen X, and Wang Y, each have co-citation counts ranging from 150 to 212. Author co-citation network analysis is a powerful tool for identifying influential scholars within a specific research domain and elucidating the nature of their collaborative relationships. The author co-citation network for a particular research field, covering the years from 2015 to 2025, is presented (Fig. 9). The size of each node in the network reflects the frequency of citations an author has received, while the lines linking the nodes represent co-citation relationships. The visualization map of co-cited authors associated with ferroptosis in CVDs. The size of nodes corresponds to the number of citations of the authors. The connections between nodes signify the co-citation associations between the authors In the network, Fang XX and Zhang J emerge as 2 of the most prominent nodes. Additionally, Stockwell BR and Gao MH are also significant nodes. The network contains several distinct clusters. For instance, there is a strong co-citation relationship between Fang XX and authors such as Wang YL and Chen X. Another cluster comprises Stockwell BR, Dixon SJ, and Xie Y. Upon examining the temporal axis, it is evident that the co-citation relationships involving Fang XX and several other key authors have significantly increased since 2020. Similarly, authors like Gao MH and Hou W have also experienced a rise in their co-citation relationships since 2018. Co-occurrence analysis of keywords and burst detection Timeline visualization of keywords The timeline visualization of keywords provides insights into the temporal dynamics and research focus shifts across various thematic clusters. This analysis uses a two-year time slice to generate a timeline that maps the evolution of keywords over time (Fig. 10). Every node indicates a keyword, with the size indicating its cumulative usage from its first appearance to the present. Nodes appearing in different years are color-coded to reflect their temporal distribution. From 2016 to 2025, prominent keywords included “cell death,” “oxidative stress,” “cardiovascular diseases,” “ferroptosis,” and “inflammation.” In the CiteSpace visualization map related to ferroptosis in CVDs, the timeline view is presented. The horizontal lines in various colors denote clusters generated by distinct keywords. Each node on these lines signifies a keyword, with its position indicating the year when the first publication containing that keyword emerged Keyword burst analysis The inception of the green line segment signifies the emergence of keyword, while the red line segment indicates the length of keyword bursts (Fig. 11). Notably, there were no significant keyword bursts prior to 2020. During the period from 2020 to 2021, keywords such as “cancer cells,” “hydrogen peroxide,” “reactive oxygen species,” and “inhibits ferroptosis” began to experience bursts. This trend continued from 2021 to 2023, with an increase in the number of keywords including “necroptosis,” “lipid metabolism,” “autophagy,” and “mitochondrial dysfunction.” Top 25 references with the most significant citation bursts. The blue bar shows that the reference has been published; the red bar represents a citation explosion Based on the keyword burst detection, the increase in research on “ferroptosis” is particularly evident from 2021 onwards. We identified articles published after 2021 that focused on this topic. There were a significant number of articles discussing “ferroptosis,” with a notable increase in the number of papers from 2022 to the present. Keywords like “cardiovascular diseases,” “myocardial infarction,” “lipid metabolism,” “autophagy,” and “mitochondrial dysfunction” also emerged as new burst keywords from 2022 to the present. Discussion Primary findings Ferroptosis, as a novel mode of cell death, has garnered substantial attention within the field of CVDs in recent years. The bibliometric analysis revealed the rapid development since 2016. From 2016 to 2025, a total of 507 relevant papers were published, indicating a yearly increase in research activity and influence. The fitting function curve analysis demonstrated that the number of publications peaked in 2024 at 248 papers, signifying that the studies are attracting an increasing number of scholars. Moreover, the average annual citation counts also reached its highest value in 2024, with 9,772 citations, further underscoring the academic significance of this research direction. Ferroptosis research in CVDs was multidisciplinary, with biochemistry and molecular biology, pharmacology and pharmacy, and cell biology as the primary disciplines, accounting for nearly 70% of published papers. From a national and institutional perspective, China not only held a leading position in this research area but also markedly exceeded the USA, with 1,188 institutions involved. Among these, Southern Medical University topped the list with 21 published articles, which reflected the robust research capacity of China and its international collaborative capabilities. The journal analysis showed that the International Journal of Molecular Sciences had published the highest number of papers. Citation network analysis revealed that journals focusing on “Molecular, Biology, Genetics” formed the core of the citation network. Co-citation analysis identified the significant role of journals such as Nature. The author analysis revealed that authors like Zhang Jing had the highest number of publications, while authors like Dixon SJ had the highest co-citation counts, indicating their substantial influence in this field. The keyword analysis demonstrated a shift in research focus over the period from 2016 to 2025, with keywords such as “cell death,” “oxidative stress,” “cardiovascular diseases,” “ferroptosis,” “reactive oxygen species,” and “inflammation.” After 2020, research on “ferroptosis” indicted a significant increase, and since 2022, new burst keywords have emerged, including “cardiovascular diseases,” “myocardial infarction,” “lipid metabolism,” “autophagy,” and “mitochondrial dysfunction.” Interpretation of key findings An in-depth examination of research on ferroptosis in CVDs shows that the number of publications and citation frequency are key indicators for evaluating the influence and progress of this area. These indicators not only reveal the importance of research findings but also highlight emerging trends. An analysis of highly cited papers indicates that pivotal studies focus on the mechanisms underlying ferroptosis induction in CVDs, including its role in cardiomyopathy and atherosclerosis, as well as the identification of novel regulatory elements like Ferroptosis suppressor protein 1 (FSP1). To begin with, the initial study in this domain, released in 2019, revealed ferroptosis as a potential target for protection against cardiomyopathy [6], which subsequently garnered substantial citations. Following this, the inquiry into the interplay between ferroptosis and cardiomyopathy has become more profound and sophisticated. It is worth highlighting that Tao et al. [22] uncovered that inhibiting ferroptosis can mitigate atherosclerosis by reducing lipid peroxidation and endothelial dysfunction in mouse aortic endothelial cells. Jiang et al. [23] offered a more comprehensive understanding of ferroptosis mechanisms, biology, and its role in diseases through their extensive review. Moreover, research conducted by Bersuker et al. [24] and Doll et al. [25] identified FSP1 as a novel regulator of ferroptosis, operating independently of glutathione peroxidase 4 (GPX4), thereby shedding light on the intricate regulatory network underlying this cell death pathway. The examination of prominent authors underscores individuals distinguished by substantial publication records and significant citation influence. In CVDs, researchers like Zhang Jing and Yan have made significant contributions. Zhang Jing has published 8 papers emphasizing the role of ferroptosis in myocardial infarction and its potential as a therapeutic strategy [26–28]. Yan, with 5 publications, has been instrumental in characterizing the epigenetic regulation of ferroptosis, shedding light on iron metabolism and lipid peroxidation [29, 30]. Wang Ying and Li Wei have also made notable contributions, with Wang Ying highlighting the role of reactive oxygen species (ROS) in CVDs and the potential of antioxidants [31–33], and Li Wei focusing on molecular pathways and identifying diagnostic biomarkers [34–36]. These authors, along with others such as Liu Ying and Zhu Lin, underscore the multidisciplinary nature of the field, bridging basic molecular biology to clinical applications. Their collaborative efforts are essential for advancing our understanding of ferroptosis in CVDs. The institutional analysis has identified Southern Medical University, Chinese Academy of Medical Sciences-Peking Union Medical College, Harbin Medical University, Zhejiang University, and University of South China as the most prolific institutions, with 21, 18, 17, 16, and 15 publications respectively. These institutions, supported by robust research foundations, have taken the lead in this domain. Network visualization further illustrates the collaborative connections among these institutions, with Zhejiang University, University of South China, and Chinese Academy of Medical Sciences-Peking Union Medical College prominently positioned at the core of the collaboration network, highlighting their pivotal roles in facilitating cross-institutional cooperation and knowledge exchange. Since 2016, a significant number of research outcomes in this area have been published across various journals. Among them, the International Journal of Molecular Sciences, Frontiers in Cell and Developmental Biology, Circulation Research, and Frontiers in Cardiovascular Medicine have played crucial roles. These journals, known for their high-quality academic content and extensive readership, have become vital platforms for researchers to publish and access cutting-edge knowledge. Co-citation analysis using CiteSpace has revealed the high co-citation frequency of journals such as Nature, Proceedings of the National Academy of Sciences, and PloS One, indicating their significant positions in knowledge dissemination and academic communication. Further analysis of citation relationships shows that journals citing in the fields of “Molecular, Biology, Immunology” and those cited in the fields of “Molecular, Biology, Genetics” form key nodes in the knowledge flow pathway, reflecting the close connection between basic research and clinical application. From a national perspective, China and the USA dominate in terms of publication output. China had made a significant contribution to this area, accounting for 34.57% of all published papers, which reflected the substantial research efforts made in exploring the application of ferroptosis in disease treatment, especially in the fields of pharmacology and gene regulation. The USA had an output of 4.31%, with a research focus on the mechanisms and regulation of ferroptosis in CVDs. This includes its effects on iron metabolism as well as the key genes, epigenetics, and advanced therapies, such as siRNA, that influence ferroptosis sensitivity [37]. Despite limited resources, research teams from resource-poor countries, such as Iran, had proposed that physical activity could affect the metabolism of lipids, amino acids, and iron, thereby modulating ferroptosis [38, 39]. While China ranked first in total citations, the USA had a higher citation rate per paper, indicating a greater research impact and quality. This may likely be attributed to higher research investment and extensive international collaboration, which enhances the visibility and influence of their research findings. The strong collaborative connections between China and the USA highlight the intrinsically global nature of research in this field. Systematic summary of ferroptosis mechanisms in CVDs Ferroptosis, a form of iron-dependent regulated cell death, has emerged as a significant mechanism in the pathogenesis of CVDs. This process is characterized by the accumulation of lipid peroxidation products and is regulated through a complex interplay of antioxidant systems, iron metabolism, and lipid metabolism. The core regulatory framework of ferroptosis is anchored by the interconnection of these three axes, where any imbalance can trigger cell death. The antioxidant system, primarily composed of the cystine/glutamate antiporter (System Xc⁻), GSH, and GPX4, plays a crucial role in maintaining redox homeostasis. System Xc⁻, a heterodimeric amino acid transporter, facilitates the uptake of cystine, which is converted to cysteine and subsequently used for GSH synthesis [24, 40]. GPX4 then utilizes GSH to reduce lipid peroxides, thereby preventing oxidative damage. Research findings suggest that interference with the GPX4/GSH/SLC7A11 antioxidant system accelerates lipid peroxide accumulation and raises ROS levels within cells, consequently inducing ferroptosis [41]. Dysfunction of this system, depletion of GSH, or loss of GPX4 activity leads to the accumulation of lipid peroxides and subsequent ferroptosis [42]. Iron metabolism is another critical pathway involved in ferroptosis. Iron overload can lead to the generation of ROS through the Fenton reaction, exacerbating lipid peroxidation. The regulation of iron homeostasis involves proteins such as ferritin, which stores iron, and ferroportin, which exports iron from cells. Disruption of these proteins can lead to iron accumulation and increased susceptibility to ferroptosis. Studies on the impact of high-iron diets on ferroptosis and cardiac damage, as well as the protective role of mechanistic target of rapamycin (mTOR) in managing iron homeostasis, have also been significantly co-cited [43]. These studies highlight the potential therapeutic targets for myocardial infarction by specifically managing iron metabolism. Additionally, the nuclear receptor coactivator 4 (NCOA4) mediates ferritinophagy, a process that degrades ferritin and releases iron, further contributing to ferroptosis [44]. Lipid metabolism also plays a pivotal role in ferroptosis. Polyunsaturated fatty acids (PUFAs) are particularly susceptible to peroxidation, and their oxidation products, such as phospholipid hydroperoxides, drive ferroptosis. Key enzymes involved in this process include acyl-CoA synthetase long-chain family member 4 (ACSL4) and lysophosphatidylcholine acyltransferase 3 (LPCAT3), which facilitate the incorporation of PUFAs into phospholipids [45]. Lipid peroxidation is further catalyzed by lipoxygenases (LOXs), leading to the accumulation of lipid peroxides and cell death [46]. Beyond these primary pathways, other mechanisms such as the FSP1-COQ10-NAD(P)H axis (FSP1 utilizes NAD(P)H to reduce ubiquinone (CoQ10) to ubiquinol, thereby scavenging lipid peroxidation radicals and inhibiting ferroptosis.) and the GCH1-BH4-DHFR axis (GCH1 catalyzes the synthesis of BH4, which is regenerated via DHFR to capture radicals, protecting cells from ferroptosis.) also contribute to ferroptosis regulation [47, 48]. These pathways provide additional layers of complexity and potential therapeutic targets for modulating ferroptosis in CVDs. In summary, ferroptosis in CVDs is orchestrated through a delicate balance of antioxidant defenses, iron homeostasis, and lipid metabolism. Understanding these mechanisms is crucial for developing targeted therapies aimed at mitigating cardiovascular damage and improving patient outcomes. Research frontiers and new topics The keyword analysis of ferroptosis in CVDs from 2016 to 2025 reveals a significant shift in research focus, with emerging themes and hotspots indicating the evolving nature of the field. Initially, keywords such as “cell death,” “oxidative stress,” “cardiovascular diseases,” “ferroptosis,” “reactive oxygen species,” and “inflammation” dominated the literature, reflecting foundational research into the mechanisms of ferroptosis. After 2020, there was a notable increase in studies focusing on “ferroptosis,” highlighting its growing importance in CVDs research. Since 2022, new burst keywords have emerged, including “cardiovascular diseases,” “myocardial infarction,” “lipid metabolism,” “autophagy,” and “mitochondrial dysfunction,” indicating a shift towards more specific and clinically relevant topics. These emerging topics underscore the intricate pathophysiology of CVDs and suggest that targeting these mechanisms could offer promising prevention and treatment strategies. For instance, the increasing focus on lipid metabolism and mitochondrial dysfunction highlights the potential for novel therapeutic interventions targeting these pathways [49–51]. Additionally, the emergence of keywords related to myocardial infarction and autophagy indicates a growing interest in understanding the role of ferroptosis in acute and chronic cardiac conditions. The analysis of burst references further supports these trends, identifying key papers that have significantly impacted the field. These papers cover a range of topics, from the molecular mechanisms of ferroptosis to its role in specific CVDs, providing a foundation for future research. The identification of these emerging trends and hotspots not only enhances our understanding of ferroptosis in CVDs but also facilitates the rapid translation of these findings into clinical practice, thereby accelerating the development of new diagnostic and therapeutic methods. Future work will benefit from employing multi-omics approaches to comprehensively understand the cellular and molecular changes associated with ferroptosis, thereby facilitating the development of effective therapies, with a particular focus on clinical applications and the development of innovative treatments for CVDs. Limitations This study shows a comprehensive bibliometric analysis of 507 scholarly papers related to ferroptosis and CVDs in the WoSCC database. Utilizing diverse analytical methods, it explores the research hotspots and future trends in this field, providing a reference for the study of ferroptosis and CVDs. The comprehensive and systematic review of the latest progress in this domain significantly enhances the academic value and practical significance of this research, offering important guidance for the future development of the field of ferroptosis and CVDs. However, there are some limitations to this study. Firstly, our focus on English-language publications limits the comprehensiveness of the study, excluding high-quality non-English research. Secondly, all data are sourced solely from the WoSCC database, which may not cover all relevant literature from other databases (such as PubMed, Google Scholar, and Scopus), potentially introducing bias. Finally, the manual screening of literature may be subject to the subjective judgment of researchers, lacking a unified standard and objectivity. This may compromise the integrity of the literature collection and the reliability of the analysis results. Despite these limitations, WoSCC was chosen as the primary data source due to its extensive coverage of core articles in biomedical research and its widespread use in bibliometric analyses. The quality of the study data is crucial for the credibility of the generated knowledge maps, further justifying our choice of WoSCC. Similar limitations have also been reported in other bibliometric studies [52–54]. Future directions The future directions in the study of ferroptosis in CVDs are likely to focus on several key areas that hold significant promise for advancing our understanding and developing novel therapeutic strategies. Future research should aim to further elucidate the molecular mechanisms underlying ferroptosis in CVDs, with a particular emphasis on lipid peroxidation, iron metabolism, and oxidative stress. The identification of novel regulatory proteins and pathways will be crucial for developing targeted therapies, as these mechanisms play a central role in the induction and regulation of ferroptosis. In parallel, the development of reliable biomarkers for ferroptosis is essential for early detection and monitoring of CVDs. Future studies should focus on identifying and validating biomarkers that can accurately reflect the presence and extent of ferroptosis in clinical samples, thereby facilitating the translation of basic research findings into clinical practice. Optimizing detection methods for ferroptosis is another critical area for future research. Current methods are often limited by low sensitivity and specificity, and frequently require expensive techniques, such as costly equipment and specialized reagents. Future efforts should aim to improve detection accuracy and reduce costs, enabling more widespread use of ferroptosis detection in both research and clinical settings. The therapeutic potential of modulating ferroptosis in CVDs is a promising area for future research. Studies should focus on developing small molecules, genetic probes, and other interventions (such as exercise and nutrition) that can specifically target ferroptosis pathways. Preclinical and clinical trials will be essential for evaluating the efficacy and safety of these potential therapies, paving the way for novel therapeutic approaches. Future research should also expand the scope of disease models to include a broader range of CVDs, such as cardiovascular toxicity, diabetic cardiomyopathy, and heart failure. This will provide a more comprehensive understanding of the role of ferroptosis in various cardiovascular conditions and identify new therapeutic targets. Finally, fostering global collaboration is essential for advancing the study of ferroptosis in CVDs. Future efforts should focus on building partnerships between institutions and countries to share resources, expertise, and data. This collaborative approach will be crucial for addressing the challenges associated with ferroptosis research and accelerating the development of effective therapies. Conclusion The study of ferroptosis in CVDs is a rapidly evolving field with significant translational potential. Our bibliometric analysis has illuminated the progress made in this domain and identified key directions for future research, which are crucial for advancing our understanding of disease mechanisms and developing novel therapies. Future studies should continue to elucidate the molecular mechanisms of ferroptosis to enhance its clinical applicability and accelerate discoveries and innovations in this field through global collaboration and interdisciplinary research. Acknowledgements This study was greatly supported by the Library of Southeast University, especially in terms of technical guidance and resource provision for data acquisition and analysis from the WoSCC database. The completion of this study would not have been possible without the hard work and contributions of all members of the research team. Finally, we extend our gratitude to all colleagues and friends who participated in and supported this study. Abbreviations Acyl-CoA synthetase long-chain family member 4 Cardiovascular diseases Ferroptosis suppressor protein 1 Fat mass and obesity-associated protein Glutathione Glutathione peroxidase 4 Lysophosphatidylcholine acyltransferase 3 Lipoxygenases Methyltransferase like 3 Mechanistic target of rapamycin Nuclear receptor coactivator 4 Polyunsaturated fatty acids Reactive oxygen species Web of science core collection Author contributions XZ and XC: Conceptualization, Validation, Supervision, Writing-original draft, Writing-review. LL and XC: Methodology, Data curation, Software, Writing-editing. WX: Formal analysis, Writing-original draft. YG: Data curation, Software, Writing-original draft. YH: Funding acquisition, Resources, Software, Supervision, Writing-review&editing. All authors participated in the preparation of the manuscript and endorsed the version submitted for publication. Funding This study was supported by Jiangsu Provincial Key R&D Programme (No. BE2023023-1). The mentioned funding project primarily focuses on engineering development. However, the methodological support it provided, particularly in data analysis, offered valuable interdisciplinary resources for this study. The current research on ferroptosis in CVDs was conducted independently and only partially utilized these resources. Data availability No datasets were generated or analysed during the current study. Declarations Ethics approval and consent to participate Not applicable for that section. Consent for publication Not applicable for that section. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Xianghu Zhao, Xiaohan Cao and Lan Lei contributed equally to this work. References Associated Data Data Availability Statement No datasets were generated or analysed during the current study.